10-Q: Green Planet Bioengineering Q1 2026 Financial Update

Green Planet Bioengineering Co., Ltd. reports continued operational inactivity and reliance on related party funding for Q1 2026, with a net loss of $10,944.

Summary

• Green Planet Bioengineering Co., Ltd. (the Company) has filed its Form 10-Q for the quarterly period ended March 31, 2026.
• The Company continues to operate as a public reorganized shell corporation with the stated purpose of acquiring or merging with an existing business operation.
• There were no active business operations during the three months ended March 31, 2026, and expenses primarily consisted of accounting and filing fees.
• The Company reported a net loss of $10,944 for the three months ended March 31, 2026, compared to a net loss of $6,840 for the same period in 2025.
• Administrative expenses were $10,794 for Q1 2026, an increase from $6,840 in Q1 2025.
• Interest expenses were $150 for Q1 2026.
• The Company's ability to continue as a going concern is dependent on continued support from a related party of the majority stockholder, which raises substantial doubt.
• As of March 31, 2026, the Company had a working capital deficit of $511,920 and an accumulated deficit of $1,141,540.
• The amount due to a related party was $501,321 as of March 31, 2026, an increase from $484,678 as of December 31, 2025.
• The Company had no commitments or contingencies as of March 31, 2026.
• Subsequent to the quarter, the related party advanced the Company $3,850 from April 1, 2026, through the filing date.
• The number of common shares outstanding as of May 15, 2026, was 20,006,402.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the increased net loss, widening working capital deficit, and the explicit statement of substantial doubt regarding the company's ability to continue as a going concern, despite the absence of active business operations.

Positives

• The Company's disclosure controls and procedures are designed at a reasonable assurance level and are effective.
• There were no changes in internal control over financial reporting that materially affected the controls during the quarter.
• A related party advanced $3,850 to the Company in early April 2026, indicating continued financial support.

Negatives

• The Company had no active business operations during the quarter.
• The Company incurred a net loss of $10,944 for the three months ended March 31, 2026.
• The Company has a working capital deficit of $511,920 and an accumulated deficit of $1,141,540 as of March 31, 2026.
• The Company's ability to continue as a going concern is subject to substantial doubt due to its reliance on related party funding.
• The amount due to a related party increased to $501,321 as of March 31, 2026.

Risks

• The Company's ability to continue as a going concern is dependent on continued support from a related party of the majority stockholder, giving rise to substantial doubt.
• The Company's ability to implement and execute future business plans and generate sufficient revenue is directly influenced by its ability to secure adequate financing or find profitable business opportunities.
• If profitable business opportunities are not identified in the near term, the Company will experience delays in effecting its business plans.
• Actual results may differ significantly from forward-looking statements due to various risks and uncertainties.

Future Outlook

The Company's future outlook is contingent on securing adequate financing and identifying profitable business opportunities. Without these, business plans may be delayed. The Company will continue to source funding from future investors to execute business opportunities when they arise.

Management Comments

• The unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions under Regulation S-X of the Securities and Exchange Commission (SEC) Form 10-Q.
• In the opinion of management, all adjustments considered necessary for a fair presentation, consisting solely of normal and recurring adjustments have been made.
• The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation.
• The Company had no active business operations for the periods ended March 31, 2026 and March 31, 2025.
• Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying unaudited condensed financial statements.
• Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q.
• Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of the fiscal period end, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SECs rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Industry Context

StockSavvy.ai notes that Green Planet Bioengineering Co., Ltd. is operating as a shell company, a common structure for entities seeking to merge with or acquire an operating business. This strategy is prevalent in industries undergoing consolidation or where companies aim to bypass the lengthy process of a traditional IPO. However, the significant going concern risks highlighted in this filing are typical for such entities that lack current revenue streams and rely heavily on external funding.

Comparison to Industry Standards

• As a shell corporation with no active operations, direct comparison to industry standards for revenue, profitability, or operational efficiency is not applicable.
• The reliance on related party funding for operational expenses is a common, albeit risky, practice for early-stage or shell companies. However, the substantial doubt about going concern is a critical indicator that warrants close monitoring.
• The net loss of $10,944 for the quarter is minimal in absolute terms but significant relative to the Company's current operational state, underscoring its status as a pre-revenue entity.

Legal Proceedings

• None

Related Party Transactions

• The Company relies on a related party of the majority stockholder to advance funds to finance its operating expenses.
• The Company's Chief Executive Officer, Chief Financial Officer and Director of the Company is also a director of the related party.
• Amounts advanced by the related party are interest-free, unsecured and are repayable upon demand.
• The amount due to a related party was $501,321 as of March 31, 2026.
• The related party advanced the Company $3,850 from April 1, 2026, through the date of filing.

Stakeholder Impact

• Shareholders: The continued lack of operational activity and the substantial doubt about the going concern status pose significant risks to shareholder value. Future value is entirely dependent on successful acquisition or merger.
• Creditors: The company's liabilities are primarily to a related party, and its ability to repay any debts is uncertain given its current financial state.
• Management: Management's compensation and operational decisions are heavily influenced by the need to secure funding and identify a suitable business to acquire or merge with.

Next Steps

• The Company will continue to source adequate funding from future investors to execute business opportunities when they arise.
• The Company will continue to operate as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation.

Key Dates

Recommendation

Given the company's status as a shell corporation with no active operations and significant going concern risks, a 'hold' recommendation is appropriate. Investors are essentially betting on a future acquisition or merger. The increased net loss and widening deficits in this quarter, while concerning, do not fundamentally alter the speculative nature of the investment. Further developments regarding a potential business combination or significant funding would be required to warrant a stronger recommendation.

Keywords

Green Planet Bioengineering, 10-Q, Quarterly Report, Shell Corporation, Going Concern, Related Party Transaction, Net Loss, Financial Statements, SEC Filing